Nayden Denis 4
4 · Accretive Health, Inc. · Filed Jan 3, 2013
Insider Transaction Report
Form 4
Nayden Denis
Director
Transactions
- Award
Director Stock Option (right to buy)
2013-01-02$5.68/sh+2,639$14,990→ 2,639 totalExercise: $11.70From: 2013-01-02Exp: 2023-01-02→ Common Stock (2,639 underlying)
Footnotes (1)
- [F1]This option was issued to the reporting person pursuant to the Accretive Health director compensation plan in lieu of retainer fees of $15,000.